Skip to content
AgingResearch.News
  • HomeHome
  • SearchSearch
  • AskAsk
  • FollowingFollowing
  • SavedSaved
Join freeSign inSign inSign in
AgingResearch.NewsJoin free

miR-103A-3P inhibitor

miR-103A-3P inhibitor has been studied in 1 paper since 2025: 1 observational study in people. The newest paper, Mar 2, 2025: “Diabetes Advances Cardiomyocyte Senescence Through Interfering Rnd3 Expression and Function”.

Intervention

1 paper studies itUpdated Mar 2, 2025

  • Humans1

Latest

Aging Cell·Mar 3

Diabetes Advances Cardiomyocyte Senescence Through Interfering Rnd3 Expression and Function

Study in peopleCellular senescence
Paper

Related

  • Cellular senescence1
  • JAK–STAT signaling1
  • MIR103A11
  • Proteasome1
  • RND31
  • SASP1
  • STAT31
  • Senescence-associated secretory phenotype (SASP)1
  • Ubiquitin–proteasome system1
  • AAV9-miR-103A-3P sponge1
  • Diabetes mellitus1
  • Diabetic cardiomyopathy1
  • p-STAT31
  • RND3-overexpressing plasmid1
  • Senescence-associated beta-galactosidase1
FooterAI assistantsComparePrivacyTermsContactRSSFollow on X
© 2026 AgingResearch.News
Sidebar

    Join AgingResearch.News

    Free: every story, saved papers, follows, the weekly digest and 3 questions a day to Ask.

    Continue with email

    By continuing, you agree to our Terms and Privacy Policy.

    News

    See allSee all news
    ALSEA Award honors breastfeeding and biological aging research in persistent obesityFundingInfogate.cl +3Fish oil supplements fail to slow brain shrinkage or memory loss in trialTrialsScienceDailyEos SENOLYTIX presents mitochondrial-targeted peptide results featuring a 167-week-old treated mouseConferenceLongevity.Technology

    Trials

    See allSee all trials
    Fatigability of Lower Limb Muscle in Older Adults: Protective Effects of Strength Training Exercise in Old Men and WomenResults posted Oct 13, 2026, Marquette UniversityBenefits of Strength Training in Informal Caregivers of Patients With Alzheimer's DiseaseCompleted Oct 16, 2026, University of SalamancaFisetin for Improving Vascular Function in Older Adults: A Phase II Clinical TrialPhase 2Registered Oct 13, 2026, University of Colorado, Boulder

    Trending

    See allSee all trending stories
    Sleep durationIntervention20 papers in two weeks, usually 1Postoperative complicationsDisease14 papers in two weeks, usually 1Metabolic disordersDisease11 papers in two weeks, none in the two months beforeChronic diseaseDiseaseFrailty changes linked to chronic disease risk in China, and 1 more story this weekIncident strokeDisease10 papers in two weeks, none in the two months beforeEnlicitide decanoateInterventionFirst trial results posted: A Clinical Study of Enlicitide in Participants With Severe Renal Impairment (MK-0616-032)

    Topics

    See allSee all topics
    Mechanisms264Interventions546Biomarkers420Populations645AI & data123Industry & policy17SupplementsPeptidesProtocols
    Footer
    • AI assistants
    • Compare
    • Privacy
    • Terms
    • Contact
    • RSS
    • Follow on X
    • © 2026 AgingResearch.News